You just read:

Glenmark Therapeutics Expands Specialty Portfolio with OTIPRIO® Co-Promotion Agreement in the U.S. with Otonomy for Acute Otitis Externa Indication

News provided by

Glenmark Therapeutics Inc., USA

May 02, 2019, 09:00 ET